Award_Synopsis.pdf
PDF 13 KB Posted
- Attached to
- Staged Vaccine Development Federal contract opportunity
- Solicitation number
- BAA-NIAID-DAIDS-NIHAI2014014
About this file
Award Synopsis 2 - University of Massachusetts Medical School
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Award_Synopsis.pdf | ||
| Amendment_3_NIAID-DAIDS-NIHAI2014014_FINAL.pdf | ||
| Amendment_2_NIAID-DAIDS-NIHAI2014014.pdf | ||
| Amendment_1_NIAID-DAIDS-NIHAI2014014.pdf | ||
| Solicitation_SVD_BAA_No_NAID-DAIDS-NIHAI2014014-Attachments_1-22.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
AWARD SYNOPSIS
Type: Award
Date of Award: May 15, 2016
Period of Performance (including all options): May 15, 2016 through May 14, 2023
Title: "Production of a Quadra-Valent Recombinant gp120 Protein Vaccine Formulation for Clinical Testing”
(RFP) No.: NIAID-DAIDS-NIHAI2014014
NAICS: 541712, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Contract Number: HHSN272201600011C (University of Massachusetts Medical School)
Total Estimated Cost (Including all Options): $17,298,573 (University of Massachusetts Medical School)
Place of Performance/Awardee:
University of Massachusetts Medical School 55 Lake Avenue North Worcester, MA 01655
Primary Point of Contact at NIAID: Kishan Patel Contracting Officer patelki@niaid.nih.gov mailto:patelki@niaid.nih.gov
File details come from the government source that posted it. Updated .